Recurring GPC5 (Glypican 5) gain/amplification has been detected in a subset of ECS, mostly in the sarcoma component, and the authors linked the involvement of GPC5 with sarcomatous transformation [61]. The gene discussed is GPC5; the disease is sarcoma.